Navigation Links
Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
Date:9/12/2013

are generally not susceptible to the most common strain of HIV.

Summary of Clinical Trial Design
About SB-728-902 Cohorts 1-3
The study is an open-label Phase 1 clinical trial to evaluate the safety and tolerability of single infusions of an escalating dose of an autologous (a patient's own) CD4+ T-cell product genetically modified at the CCR5 gene by CCR5-specific ZFNs (SB-728-T). The trial enrolled nine HIV-infected subjects (three cohorts of three subjects each) who have sub-optimal T-cell levels and no detectable viral load on long-term ART.  Subjects remained on their existing antiviral therapy while receiving treatment with SB-728-T.

About SB-728-902 Cohort 5
Up to 20 HIV-infected subjects heterozygous for the CCR5 delta-32 mutation (i.e. with one CCR5 gene that is naturally modified) who are currently on ART are being enrolled and will receive a single intravenous infusion of SB-728-T (5 to 30 billion modified cells). Two months after SB-728-T treatment, subjects undergo a 16 week TI during which time their ART is discontinued. ART will be reinstituted in subjects whose CD4 T-cell counts drop to <350 cells/ mm3 and/or whose HIV-RNA increases to >100,000 /mL for three consecutive weekly measurements. At the end of the TI, subjects with a sustained detectable HIV viral load are reinstituted on ART. Subjects with an undetectable viral load can remain off ART until HIV RNA levels are detectable or their CD4 T-cell count drops below 350 cell/mm3 for three consecutive weekly measurements.

A total of ten subjects have been treated in this cohort. 

Of the six evaluable subjects, we observed two subjects in which their VL became undetectable during TI from ART:

  • In one subject, VL suppression at, or below, the limit of quantification (LOQ) of virus was sustained from week 11 – 19 of TI and the TI is ongoing.
  • In the s
    '/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sangamo BioSciences to Acquire Ceregene
2. Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
3. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
4. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
5. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
6. Sangamo BioSciences Reports First Quarter 2013 Financial Results
7. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
8. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
9. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
10. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
11. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
(Date:12/17/2014)... BUENA, N.J. , Dec. 17, 2014  IGI ... announced today the closing of its offering of $125 ... due 2019 (the "Notes").  The Notes were offered and ... 144A under the Securities Act of 1933, as amended ... at a fixed rate of 3.75% per year, payable ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... According to new data published in Clinical ... have a significant impact on whether patients take it ... packaging from MeadWestvaco Corp. (NYSE: MWV ), ... improvement in prescription adherence behavior in patients when compared ...
... YORK, June 16, 2011 Reportlinker.com announces that ... its catalogue: US Wound Closure ... http://www.reportlinker.com/p0555195/US-Wound-Closure-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Short ... vital market data on the wound closure devices ...
Cached Medicine Technology:Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 2Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 3Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 4Shellpak® Demonstrates Statistically Significant Improvement in Patient Medication Adherence 5Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016 2
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
(Date:12/15/2014)... 2014 Health Dialog, a leading ... that it has received Patient Oriented Accreditation from ... its Disease Management (DM) Programs for asthma, congestive ... heart disease and diabetes. This marks the 12th ... Dialog’s Disease Management (DM) Programs, reaffirming Health Dialog’s ...
(Date:12/15/2014)... SUNDAY, Dec. 14, 2014 (HealthDay News) -- Expert pilots ... which explains why they make better decisions during landings, ... the most difficult techniques for pilots to master, and ... of fatal crashes occur during final approach and landing. ... pilots and 12 moderately experienced pilots while they were ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Kathy McAfee, ... prestigious Women World Awards in the category of Best ... gold award for her weekly career blog Networking ... advice to help professionals elevate their talent and influence ... blog, named after her book Networking Ahead for Business, ...
(Date:12/15/2014)... Portland, OR (PRWEB) December 15, 2014 ... NAIRO seeks to bring attention to restrictive state ... new position paper on this important area of ... State Laws Can Compromise the Integrity of Independent ... quality and access of independent peer review determinations ...
Breaking Medicine News(10 mins):Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... altered the social and sexual landscape in ways expected and ... of women have taken it at some point in their ... been arrested for it and it,s still one of the ... simply known as "the Pill." , On May 9, 1960, ...
... ... valuable information regarding the signs and symptoms of chiropractic stroke and the causes of ... ... has represented people severely injured by chiropractic neck manipulations, has launched a new website ...
... ... a hospital knows just how stressful and time consuming it is to provide ... launch of a new iPhone tool called howsthepatient, it will now be possible ... choose who you want to communicate with, share health alerts, send pictures, and ...
... ... of every milestone leading to regulatory approval for,Alair® and Provenge®, , ... Lansdale, PA (PRWEB) ... announces the release of two reports on first-of-a-kind technologies just approved by the ...
... ... Society of Investigative Dermatology (SID) at the society’s annual meeting in Atlanta. ... Atlanta, GA (PRWEB) ... at the prestigious Society of Investigative Dermatology (SID) at the society’s annual meeting in ...
... ... Palliative Care Summit, conducted last fall by the Southern Illinois University Edwardsville School of ... training for pharmacists. The recommendations were release at the 29th Annual Scientific Meeting of ... ...
Cached Medicine News:Health News:The Pill Turns 50 2Health News:The Pill Turns 50 3Health News:The Pill Turns 50 4Health News:The Pill Turns 50 5Health News:Chiropractic Stroke Website Launched To Aid Victims of Chiropractor Malpractice 2Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 2Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 3Health News:New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family 4Health News:Hayes, Inc. Technology Prognosis Team Tracks First-of-a-Kind Technologies 2Health News:Aderans Research Presents at SID (Society of Investigative Dermatology) 2Health News:Aderans Research Presents at SID (Society of Investigative Dermatology) 3Health News:SIUE Pain Summit Recommendations Announced Today 2Health News:SIUE Pain Summit Recommendations Announced Today 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: